Recent recommendations from the International Society of Urological Pathology (ISUP) and the Genitourinary Pathology Society (GUPS), along with the 5th edition of the WHO Classification of Tumours: Urinary and Male Genital Tumours, novel classification and ancillary studies, and evolving clinical management guidelines have introduced substantial updates in the diagnosis of urologic malignancies. These changes present challenges for surgical pathologists to consistently apply current criteria in routine practice.
This session will provide a practical review of key updates in the classification and diagnosis of bladder, kidney, testicular, and prostate cancers. Emphasis will be placed on the application of updated diagnostic criteria, incorporation of new terminology, and alignment with current clinical management guidelines to support accurate diagnosis and effective communication in clinical practice.
Presentations
Donna E. Hansel, MD, PhD
University of Texas MD Anderson Cancer Center
Learning Objectives
Develop approaches to diagnose flat and papillary bladder lesions.
Identify approaches to determine the extent of T1 disease.
Recognize mimickers of bladder neoplasia.
Jesse McKenney, MD
Cleveland Clinic
Learning Objectives
Enumerate and differentiate the morphologically overlapping renal tumors with oncocytic (eosinophilic) features.
Rafael E. Jimenez, MD
Mayo Clinic
Learning Objectives
Identify the key features in distinguishing the different germ cell tumors of the testis and their most common differential diagnoses.
Understand the differences in biologic behavior and therapeutic implications of testicular postuberal teratomas, testicular prepubertal teratomas, and teratomas at other sites.
Identify and resolve most common problems in the staging of germ cell tumors.
Gladell P. Paner, MD, FCAP
University of Chicago Medical Center
Learning Objectives
Define and apply new criteria for diagnosis, grading, and reporting prostate cancer in biopsy.